Protein first, every day.
One focus a day, built into every meal. The plan follows the weekly shot: more protein early, lighter food on the days appetite drops.
Nutrition support for GLP-1 care
Your patients eat less. Every meal has to count.
Nibblio is a GLP-1 nutrition companion for physician-supervised care. It turns protein targets into today's meals and this week's shopping list, and supports patients between visits.
Food guidance only. Clinical decisions stay with the physician.
The gap
Eating less doesn't mean eating well.
On GLP-1 therapy, patients eat far less, but their protein and micronutrient needs stay. They're told to “eat more protein”, but create the meals alone between visits.
Appetite, % of usualProtein, % of daily target
16–39%lower daily calorie intake on GLP-1 therapy, compared with placebo
43%of people on GLP-1 therapy met the minimum protein target (1.2 g/kg/day), in one study
~1 in 4kg lost can be lean mass, which includes muscle, not just fat
Sources: Mozaffarian et al., Am J Clin Nutr 2025; Johnson et al., J Int Soc Sports Nutr 2025; Šantić et al., Metabolites 2026.
How Nibblio reaches patients
One program. Three sides that benefit.
Clinics and pharmaceutical companies offer Nibblio to people on treatment. Patients use it every day. Doctors see how the plan is going before the next visit.
1
A partner offers Nibblio
A clinic, or a pharmaceutical company's support program, gives the patient an access code.
2
The patient follows the plan
Meals, reminders and adjustments for hard days, every day of treatment.
3
The doctor sees progress
A one-page overview before each check-up, shared with the patient's consent.
For patients
Daily guidance built around the treatment, with protein first and gentler days when they are needed.
For clinics
Patients who keep to the plan between visits, and an overview before each one, with no extra work for the team.
For pharmaceutical companies
A patient support program for the first months, when it is hardest to stay on treatment.
For patients
A companion for every day of treatment.
Hard days don't break the plan.
Feeling sick or not hungry? That day gets smaller, gentler meals, and the week still balances out.
Reminders that know the treatment.
A nudge ten minutes before each meal, an evening protein check, a reminder on dose day, and a heads-up the evening before the day that is usually hardest for you.
12:35
Lunch at 12:45Turkey & egg salad · 30 g protein
Protein check28 g to go today. A small protein snack closes the gap.
Dose dayProtein first today, smaller portions, plenty of water.
Logging takes a second.
Tap "I had what was planned", snap a photo, or just say what you ate.
Swap a meal. Shop from the plan.
Any meal can be swapped for one that hits the same target. The shopping list comes from your plan for 3, 5 or 7 days, with the amounts added up, and shows the week as a whole.
Progress you can read.
Protein day by day, weight from your weigh-ins, and lab results as printed on the report. Before a check-up, share a short PDF overview with your doctor.
Every Sunday
A week worth sharing.
A short recap of your week, built from the days you logged: days on target, protein, and the hard day you got through. Gold in Nibblio always means you did it.
For clinics
Continuous support between visits. Clinical decisions stay with you.
Your team leads the treatment. Between visits, Nibblio helps patients with everyday food questions, so they feel supported throughout the process.
Overview for the doctor · week 44Part of the clinic pilot
| Patient | Week | Protein, avg / goal | Days on plan | Hard days |
|---|---|---|---|---|
| P-014 | 6 | 92 / 110 g | 6 / 7 | 2 |
| P-021 | 3 | 71 / 100 g | 4 / 7 | 3 (worth a word) |
| P-033 | 10 | 104 / 105 g | 7 / 7 | 0 |
| P-047 | 2 | 58 / 95 g | 3 / 7 | 4 (worth a word) |
Daily nutrition support
Meal plans, swaps and shopping lists built for a smaller appetite.
Pre-visit summaries
What changed, what worked, what to discuss. In development.
Fits your existing workflow
No new systems for your team: you onboard the patient, Nibblio covers the food side between visits.
1
The doctor enrolls the patient
At the check-up the patient gets a code or QR and installs the app. Consent is given in the app.
2
The patient gets a plan and reminders
Meals that fit their rhythm, a reminder before each meal, adjustments for hard days and a weekly recap.
3
You get an overview before the visit
Protein, days on plan, hard days and weight, on one page.
Pharma
Fund patient support. Not prescriptions.
Pharma funds a defined number of programme seats. The programme stays manufacturer-neutral, open to any adult on GLP-1 therapy under physician supervision, whichever medicine they were prescribed.
Fixed fee for service capacity
Never linked to prescriptions, products or volume.
Aggregate reporting only
Programme engagement and experience above a minimum group size. No patient-level or product-level data.
No say in clinical content
Nibblio keeps full editorial control.
No value to prescribers
No payments, gifts or benefits from sponsors to any doctor or clinic.
Pilot 2027
500 patients in Serbia, evaluation agreed with our partners.
We're preparing a 12-month programme with partner clinics and pharma companies. Before it starts, we agree on what to measure: patients reaching their protein target, weekly use, time in the programme, and what patients and doctors think of it.
How we work
Clear lines, written down.
Food guidance only
No diagnosis, no dose advice, no medicine names in any data patients see.
The patient owns their data
Explicit, revocable consent. Patient-level data goes only to the patient and, if they agree, their own physician.
Built on published guidance
Protein and meal logic follow current nutrition guidance for GLP-1 therapy.
Measured, not promised
We report what we measure in the pilot, including what doesn't work.
Where we are
Built, tested, opening up.
Built and working
The app is built and runs on iPhone and Android.
Now
Private test
Invited users, in small groups, so we can listen to each of them.
Public beta
Q4 2026.
Clinic and pharma pilots
Open for conversations now.
Team
The people building Nibblio.
Chiheb Guerfel, MD
Co-founder & CEOMedical doctor and founder of Poseidon CRO, a clinical research group across Europe, the Balkans and MENA.
Miroslav Jugović
Co-founder & CTO12+ years building AI data products; production AI for BMW, Porsche, Volkswagen and ASML.
Milan Milošević
Co-founder & CPO10+ years designing AI SaaS products, 5+ as CPO at Apon, with products for Siemens, Bosch, CERN and UN-Habitat.
Biljana Bokić
Founding member & Operations LeadOperations and research, including finance operations at Foursquare.
Science and Technology Park Novi Sad · Fruškogorska 1, Novi Sad, Serbia
Questions
Questions people ask.
What is Nibblio?
Nibblio is a companion app for people on GLP-1 treatment. It plans each day around the treatment: what to eat next, how much protein is still missing, and what to do on days with nausea or low appetite. Clinics and pharmaceutical companies offer it to their patients.
Which GLP-1 medicines does Nibblio work with?
Any of them, including semaglutide, tirzepatide and liraglutide. Nibblio follows the treatment the doctor has prescribed. It does not recommend a medication or a dose.
Does Nibblio replace a doctor or dietitian?
No. Nibblio gives food guidance only. It doesn't diagnose, prescribe or advise on doses, and decisions about the medication, the dose and your health stay with the doctor. We document its device-software classification and review it before adding any feature.
Why does Nibblio put protein first?
Weight lost on GLP-1 treatment can include muscle, especially when protein drops with appetite. Nibblio sets a daily protein focus, builds every meal around it, and shows in the evening how much protein is still missing.
What happens on a day with nausea or no appetite?
Tell the app it's a hard day. That day gets smaller, gentler meals with protein still in each one, and the rest of the week adjusts.
How can a clinic or pharmaceutical company work with Nibblio?
Through a pilot. A clinic enrols patients with a code or QR at a visit and receives a one-page overview before each check-up. A pharmaceutical company can run Nibblio as a patient support program, co-branded or under its own brand.
Who can see my health data?
Only you, and the clinic or program you choose to share it with. Data is processed under Serbia's Law on Personal Data Protection and GDPR, it is used only for your plan, and you can delete your account at any time.
What does a pharma company see?
Aggregate programme metrics above a minimum group size. Never identities, patient-level data, product-level data or free text.
Who pays?
Pharma companies fund programme seats for a fixed monthly fee. Patients join through their clinic, and individual subscriptions are also available. We share pricing in a pilot conversation.
Where is data stored?
Hosting and any transfers outside Serbia are assessed against Serbian data-protection law and GDPR, with a data protection impact assessment before launch.
Who is Nibblio not for?
If every one of your patients already sees a dietitian each week, you probably don't need us. Nibblio is for care teams that can't cover daily food questions between visits.
What stage are you at?
We have a working prototype and are preparing a 500-patient pilot in Serbia for 2027. We don't claim clinical results.
When can I start using Nibblio?
Nibblio is in a private test with invited users now, and the public beta is planned for Q4 2026. Leave your email and we'll send an invite when your spot is ready.
Contact
Let's talk about your patients.
Tell us who you are and we'll set up a 30-minute call about the 2027 pilot.